This activity is supported by an educational grant from Eisai, Inc.
Diagnosing and Treating Chemotherapy-Induced Nausea and Vomiting: Understanding the Need and Clinical Data for Best Patient Care
Hope S. Rugo, MDProfessor of MedicineDirector, Breast Oncology Clinical Trials EducationDepartment of Medicine, Division of Hematology/OncologyUniversity of California San Francisco Medical CenterSan Francisco, California
Current Clinical Practice for Chemotherapy-Induced Nausea and Vomiting: Understanding the Up-to-Date Evidence-Based Guidelines for Prevention and Treatment
Una Hopkins, RN, DNPAssistant Professor, New York University NursingAdministrative Director, White Plains Hospital Cancer CenterWhite Plains, New York
Contributing Editorial Support
Anna Azyolinsky, PhDMedical ConsultantNew York, New York
Beatriz Manzor Mitrzyk, PharmD, BCPSMedical ConsultantNorthville, Michigan
Activity Overview
This activity is designed to educate oncologists and oncology nurses on the optimal management of chemotherapy-induced nausea and vomiting (CINV), education on the efficacy and safety data for current and emerging agents for the treatment of CINV, and current guidelines for management of CINV.
To continue this CME, click here.
THIO Shows Lower Toxicity Than Standard Treatments in NSCLC Study
July 25th 2024A phase 2 trial shows that THIO, a new investigational drug, combined with cemiplimab, may be an effective and well-tolerated treatment for patients with advanced non–small cell lung cancer who have exhausted other options.
Read More
Peers Discuss Sacituzumab Govitecan in HR+ mBC Post Endocrine Therapy
July 24th 2024During a Case-Based Roundtable® event, Tiffany A. Traina, MD, surveyed participants on treatment for a patient who had progressed following endocrine therapy for metastatic breast cancer in the first article of a 2-part series.
Read More